President Trump said Friday that his administration has tapped medical supplier McKesson to spread the first vaccine for the coronavirus.
The company’s share went up by more than 4 percent on the news.
Ticker | Security | Last | Change | Change% |
---|---|---|---|---|
MCK | MCKESSON CORPORATION | 158.67 | +6.48 | + 4.26% |
Three U.S. companies are currently in Phase 3 clinical trials of faxes and are on track to develop one before the end of the year. The country expects 500 million doses to be available by Dec. 31, Trump said during a news conference.
TRUMP ADMINISTRATION: AMERICAN SEARCH CORONAVIRUS VACCINE DOES NOT WORK FOR
“Today’s announcement puts a different building block in place as the nation moves toward a safe and effective COVID-19 vaccine,” Centers for Disease Control and Prevention Director Dr. Robert Redfield said in a statement. “The march of America to one or more safe and effective COVID-19 vaccines is a combined effort between U.S. industry and the federal government.”
“McKesson is committed to supporting public health in the U.S. and around the world,” CEO Brian Tyler said in a statement. “Since the beginning of the pandemic, McKesson has utilized our deep expertise to help maintain the integrity of the healthcare supply chain, source and distribute personal protective equipment to frontline workers and stand on COVID-19 tests.”
The CDC issued an existing contract to McKesson in 2016 to distribute faxes in the event of a pandemic.
CLICK HERE TO GET FOX BUSINESS ON THE GO